今开:0.21 | 昨收:0.21 |
最高:0.21 | 最低:0.21 |
涨停价:0.0 | 跌停价:0.0 |
总市值:3.0584076E7 |
usbiostock2018-07-13 20:10
$Advaxis, Inc. (ADXS)$ FDA同意Axalimogene Filoliac联合Durvalumab临床1/2试验继续进行,用于治疗晚期、复发性或难治性宫颈癌,以及HPV相关的头颈癌。该试验曾因出现一名患者死亡而在今年3月份被FDA暂停。查看全文
药渡2018-03-13 21:53
Advaxis的免疫疗法axalimogene filolisbac与阿斯利康已获批PD-L1药物Imfinzi组合治疗HPV相关癌症正处于临床I / II期试验研究中,然而近日在研究中有患者在第六疗程之后出现呼吸衰竭而死亡,因此FDA要求暂停这项实验,并且要求调查对其他患者是否有影响。据悉此消息一公布,公司股票出现大幅下降。A...查看全文
淘沙见金2017-10-23 10:10
$Advaxis, Inc.(ADXS)$ 52周最低, 不过SITC有两个的presentation。大股东一直在卖,下一个催化剂的时间也比较远。市场对基于李斯特菌的肿瘤疗法也不是特别热情,不过当前的市值差不多才是$Aduro BioTech Inc(ADRO)$ 的1/4,勉强算是被低估的吧。查看全文
我是_一级棒2015-04-28 01:29
$ADVAXIS INC(ADXS)$ the low hanging fruit trade is SHORTING Big Winners with LOTS OF PROFITS.查看全文
白云山下掘地者2015-01-30 21:49
$ADVAXIS INC(ADXS)$ 曾经下功夫研究了一星期,去年11月初2.9买了几千股,当月2.88卖掉,没想到啊。。。。。自己看好没坚持,认了查看全文
$Advaxis(ADXS)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001493152-22-004469 Act: 34 Size: 7 MB 网页链接
$Advaxis(ADXS)$ D Notice of Exempt Offering of Securities, item 06b Accession Number: 0001493152-22-003846 Act: 33 Size: 12 KB 网页链接
$Advaxis(ADXS)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001037389-22-000004 Act: 34 Size: 13 KB 网页链接
$Advaxis(ADXS)$ 25-NSE Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities Accession Number: 0001354457-22-000116 Act: 34 Size: 4 KB 网页链接
$Advaxis(ADXS)$ PRE 14A Other preliminary proxy statements Accession Number: 0001493152-22-003228 Act: 34 Size: 359 KB 网页链接
$Advaxis(ADXS)$ 8-K Current report, items 3.02, 3.03, 5.03, and 9.01 Accession Number: 0001493152-22-002930 Act: 34 Size: 19 MB 网页链接
$Advaxis(ADXS)$ NT 10-K Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 Accession Number: 0001493152-22-002766 Act: 34 Size: 58 KB 网页链接
$Advaxis(ADXS)$ 8-K Current report, items 1.01, 3.03, 5.03, 8.01, and 9.01 Accession Number: 0001493152-22-002598 Act: 34 Size: 7 MB 网页链接
$Advaxis(ADXS)$ 8-K Current report, items 1.02 and 9.01 Accession Number: 0001493152-21-032821 Act: 34 Size: 285 KB 网页链接
$Advaxis(ADXS)$ 8-K Current report, items 3.01, 8.01, and 9.01 Accession Number: 0001493152-21-032280 Act: 34 Size: 277 KB 网页链接